Tirzepatide Was Linked to Fewer Heart Attacks in Nearly 53,000 Patients, but the Evidence Has Limits

A BMJ cohort study tied tirzepatide to a 32 percent lower risk of heart attack, stroke, or death, but it was not a randomized trial.

Have A Referral?